Fei Xiong

Title: Fei Xiong: Innovator in Enantioselective Processes

Introduction

Fei Xiong is a notable inventor based in Suzhou, China. He has made significant contributions to the field of chemistry, particularly in the development of enantioselective processes. His work focuses on creating compounds that are essential for pharmaceutical applications.

Latest Patents

Fei Xiong holds a patent for an enantioselective process for cycloalkenyl β-substituted alanines. This innovative process involves asymmetrically hydrogenating a dehydro amino acid compound in a suitable reaction medium. The presence of a catalyst with a transition metal moiety complexed to a chiral phosphine ligand allows for the preparation of enantiomerically enriched cycloalkene-substituted alanine compounds. These compounds serve as key intermediates for the ACE inhibitors ramipril and perindopril.

Career Highlights

Fei Xiong is associated with Chiral Quest, Inc., where he applies his expertise in enantioselective synthesis. His work has led to advancements in the production of important pharmaceutical intermediates. With a focus on innovation, he continues to contribute to the field of chemistry.

Collaborations

Fei Xiong collaborates with talented coworkers, including Zijun Liu and Sanhui Lin. Their combined efforts enhance the research and development capabilities at Chiral Quest, Inc.

Conclusion

Fei Xiong's contributions to enantioselective processes highlight his role as an important inventor in the field of chemistry. His innovative work continues to impact pharmaceutical development positively.